Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3158
Gene Symbol: HMGCS2
HMGCS2 		0.300 Biomarker phenotype RGD Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats. 10892723 2000
Entrez Id: 83667
Gene Symbol: SESN2
SESN2 		0.300 Therapeutic phenotype CTD_human Sestrin2 protects against acetaminophen-induced liver injury. 28209544 2017
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2 		0.300 Biomarker phenotype CTD_human Role of CYP1A2 in the toxicity of long-term phenacetin feeding in mice. 10445756 1999
Entrez Id: 1962
Gene Symbol: EHHADH
EHHADH 		0.010 GeneticVariation phenotype LHGDN Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. 9185222 1997
Entrez Id: 55315
Gene Symbol: SLC29A3
SLC29A3 		0.400 Biomarker phenotype CTD_human Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. 20140240 2010
Entrez Id: 4591
Gene Symbol: TRIM37
TRIM37 		0.400 Biomarker phenotype CTD_human Mulibrey nanism: clinical features and diagnostic criteria. 14757854 2004
Entrez Id: 2494
Gene Symbol: NR5A2
NR5A2 		0.300 Biomarker phenotype CTD_human LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. 29515023 2018
Entrez Id: 9474
Gene Symbol: ATG5
ATG5 		0.300 Biomarker phenotype CTD_human Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. 22491424 2012
Entrez Id: 9970
Gene Symbol: NR1I3
NR1I3 		0.300 Biomarker phenotype CTD_human Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides. 25656644 2015
Entrez Id: 3953
Gene Symbol: LEPR
LEPR 		0.300 Biomarker phenotype CTD_human Increased susceptibility to troglitazone-induced mitochondrial permeability transition in type 2 diabetes mellitus model rat. 29743445 2018
Entrez Id: 3073
Gene Symbol: HEXA
HEXA 		0.100 CausalMutation phenotype CLINVAR Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India. 22723944 2012
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1 		0.400 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4846
Gene Symbol: NOS3
NOS3 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 213
Gene Symbol: ALB
ALB 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 114757
Gene Symbol: CYGB
CYGB 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4843
Gene Symbol: NOS2
NOS2 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 5970
Gene Symbol: RELA
RELA 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 6927
Gene Symbol: HNF1A
HNF1A 		0.300 Biomarker phenotype RGD Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription. 28394260 2017
Entrez Id: 9971
Gene Symbol: NR1H4
NR1H4 		0.300 Biomarker phenotype CTD_human Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling. 29142166 2017
Entrez Id: 3953
Gene Symbol: LEPR
LEPR 		0.300 Biomarker phenotype CTD_human Female heterozygous (+/fa) Zucker rats as a novel leptin-related mammary carcinogenesis model. 23038009 2012
Entrez Id: 3073
Gene Symbol: HEXA
HEXA 		0.100 CausalMutation phenotype CLINVAR Expanding the spectrum of HEXA mutations in Indian patients with Tay-Sachs disease. 27896118 2014
Entrez Id: 406967
Gene Symbol: MIR192
MIR192 		0.300 Therapeutic phenotype CTD_human Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. 28483554 2017